Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2716 (LINC02716) is a member of the long intergenic non-coding RNA (lincRNA) class, transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes[1][3]. LincRNAs typically function by regulating transcription, modulating chromatin architecture, and acting as molecular scaffolds in the nucleus. They can fine-tune the expression of neighboring or related genes, often with tissue specificity, but most described biological mechanisms are general to the lincRNA family and are not specific to LINC02716 itself[1][3]. There is currently no evidence that LINC02716 acts as a direct drug target or therapeutic target, and its specific functional and disease associations remain uncharacterized in the literature[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2716 (LINC02716).